DEF 14A
ALNYLAM PHARMACEUTICALS, INC.
- Company
- ALNYLAM PHARMACEUTICALS, INC.
- Filed
- April 22, 2009
- Period of Report
- June 11, 2009
- Accession Number
- 0000950135-09-003018
A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →